Related Experiment Video
Updated: Jul 10, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Preexposure Prophylaxis for HIV Prevention in the United States: An Overview and Update
1Amit "Mickey" Dhir is a PhD student at the Johns Hopkins University School of Nursing in Baltimore, MD, and an infectious disease NP at Chase Brexton Health Care, also in Baltimore. Contact author: dhir_amit@yahoo.com. The author has disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
There were 36,136 new HIV diagnoses in the United States and dependent areas in 2021, despite a 12% reduction in estimated HIV incidence from 2017 to 2021. The burden of HIV remains disproportionately high among certain populations, including gay and bisexual men, Black/African American individuals, and Hispanic/Latino individuals, and racial and ethnic health care disparities persist. The Ending the HIV Epidemic initiative aims to significantly reduce new infections, with a focus on HIV prevention, particularly the use of preexposure prophylaxis (PrEP). However, challenges remain in achieving equitable PrEP distribution. As frontline health care providers, nurses play a pivotal role in this battle against HIV. This article provides an update on PrEP screening recommendations, the types of PrEP available, dosing, adverse effects, and the role of nurses in patient support and monitoring.
Related Concept Videos
Preclinical Development: Overview
Retrovirus Life Cycles
Sexually Transmitted Infections
Preventive Healthcare Services
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials: Overview

